PRKAA1 and early-onset autosomal dominant Alzheimer disease: In some studies, the chronic activation of AMPK has shown undesirable side effects such as cardiac and kidney hypertrophy and Alzheimer's disease, and persistent activation of AMPK can trigger apoptosis [60, 61].